Urinary Tract Infection Testing Market Size, Trends [2031]

Report Description

Urinary Tract Infection Testing Market Outlook 2031

The global urinary tract infection testing market size was USD 580 Million in 2022 and is likely to reach USD 1000 Million by 2031, expanding at a CAGR of 6.2% during 2023–2031. The market growth is attributed to the rising rate of urinary tract infections and the growing geriatric population across the globe.

Increasing geriatric population is projected to boost the urinary tract infection (UTI) testing market during the forecast period. UTI occurs frequently in aged people, particularly in those who require to be in long-term care facilities. It is a common infection due to age-related risk factors such as malnutrition, diabetes, poor bladder, constipation, long-term hospitalizations, and others.

• According to the National Institute of Health (NIH), each year around 10% of women above 65 years of age reported having a UTI. The incidence of UTI is expected to rise to 0.05 per person a year for men aged between 65 to 74 years.

Get Free Sample Report

The market report finds that the COVID-19 pandemic hindered the urinary tract infection testing market, due to the decreasing number of UTI tests conducted during the pandemic. The demand for UTI tests remained constant during the pandemic; however, the lockdown disrupted the supply chain and logistics, affecting the market. The symptoms of lower UTIs are affected by COVID-19 as the virus causes dehydration. Fever and respiratory symptoms increase the risk of UTIs. However, several manufacturing industries started their research to develop new drugs and testing kits, which fueled the market.

Impact of Artificial Intelligence on the Urinary Tract Infection Testing Market

Artificial Intelligence (AI) technologies are expected to boost the urinary tract infection market in the coming years, as these technologies help to detect infections early and prevent over-prescription of antibiotics. Early diagnosis reduces the number of patients and cases. It improves physician workflow while examining patients. AI has the potential to significantly advance physician workflow when examining patients with UTI. AI algorithms are used to identify patterns in bacterial resistance and guide antibiotic selection. AI identifies the specific bacterial species causing the infection and predicts its resistance to different antibiotics, which allows doctors to choose the effective treatment.

Urinary Tract Infection Testing Market Dynamics

Get Free Sample Report

Major Drivers

Rising number of urinary tract infection incidences is projected to boost the market during the forecast period. UTIs are commonly occurring infections, as 10 in 25 women and 3 in 25 men across the globe have the symptoms of a UTI. The burden of UTIs varies per region, social & demographic status, age group, and sex, as it is a serious health threat. An increase in the burden requires timely testing, prevention, and medication to mitigate it.

Increasing prevalence of diabetes, liver disease, and kidney disease is anticipated to fuel the urinary tract infection testing market in the coming years. Limited access to health care and education in low and middle-income nations increases the number of diabetic patients. UTIs are spread in patients with type 2 diabetes, as sugar in the urine provides a suitable environment for bacteria to grow. Liver disease and kidney disease cause chronic inflammation and liver cirrhosis, which weakens the immune response of the body to infections. For instance,

• According to the Centers for Disease Control and Prevention (CDC) in 2021, in the US, around 38.4 million individuals of all ages were diagnosed with diabetes. 38.1 million adults were aged 18 years or older.

Existing Restraints

Increasing costs of diagnostic tests hamper the market. High costs associated with these tests limit their accessibility, particularly in low-income regions where the need for affordable healthcare solutions is paramount. The growing complexity of UTI testing procedures is a concern. The need for specialized training and equipment rises, as these procedures become increasingly intricate,limiting the number of healthcare facilities that hinders the market.

Emerging Opportunities

Increasing demand for advanced and efficient combination drugs is expected to create lucrative opportunities for the market players during the forecast period. Innovative products such as self-testing and rapid Point-of-Care (PoC) devices are driving the market. Point-of-care (PoC) isa portable testing device thatperforms quick testing results. However, self-testing kits are dipsticks used to determine nitrites or leukocytes in urine, which are key indicators of UTI. Several companies are introducing self-testing kits with the help of smartphones to reduce the burden of health care systems. Thus, in turn, is likely to increase the demand for UTI self-testing kits in the market in the coming years.

• In Jan 2023, Cipla launched Cippoint, a point-of-care testing device. It allows healthcare professionals to get test results in 3 to 15 minutes, which helps in increasing the speed of clinical treatment. It provides an automatic system and user-friendly interface, which are used in rural areas, mobile vans, remote areas, and others.

Scope of the Urinary Tract Infection Testing Report

The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.

Urinary Tract Infection Testing Market Segment Insights

Infection Type Segment Analysis

Based on infection type, the urinary tract infection testing market is divided into urethritis, cystitis, and pyelonephritis.The cystitissegment is expected to expand rapidly during the projection period, due to the high recurrence rate of cystitis globally. The segment growth is further attributed to the increasing number of diabetes patients. About half of the female population have to face cystitis at least once in their lives. The highest rate of uncomplicated UTIs occurs usually between the ages of 18 and 39, due to the maximum level of sexual activity.

• According to the report published by the National Institutes of Health (NIH) in 2023, one-third of the women population have cystitis. The incidence of cystitis in men is lower than in women, which is 10 per 10000 men. Issues that increase the risk for cystitis include sexual intercourse, spermicide use, previous UTI, strong family history of UTI, and a post-menopausal state.

Get Free Sample Report

The pyelonephritis segment is anticipated to hold a key share of the market in the coming years, due to the growing number of patients suffering from kidney disease. Pyelonephritis is caused due to bacterial infection in the kidney. It shows symptoms such as fever, frequent urination, and pain in the backand side. The increasing occurrence of renal parenchymal infections caused by E. coli in patients is projected to increase the demand for UTI testing kits and drive the segment in the coming years.

Test Type Segment Analysis

In terms of test type, the global market is segregated into urinalysis, urine cultures, and susceptibility testing.The urinalysis segment is projected to register a considerable CAGR during the forecast period, due to an increase in the number of the aged population. The segment growth is further attributed to the rising demand for the diagnosis of urinary tract infections, kidney diseases, and diabetes. A urinalysis is a type of test that includes checking the contents, concentration, and appearance of the urine. For instance,

• According to the Centers for Disease Control and Prevention, chronic kidney disease is more common in individuals aged 65 years or olderwhichis 34% than in people aged 45-64 which is 12 %, or 18-44 years whichis 6 %.

Test Kit Analysis

On the basis of testkit, the urinary tract infection testing market is segmented into home test kits and laboratory test kits. The home test kits segment is expected to register a robust growth rate during the forecast period, as it is designed to detect UTIs in home settings. Home test kits are user-friendly and easily available as well as offer quick results, early detection of health conditions, and others. UTI testing kits are typically used as a strip or dipstick that is immersed in a urine sample for quick results.

• In May 2020, Healthy.io launched Velieve, a smartphone urine test for women, which helps with same-day at-home UTI testing and treatment service. It uses a smartphone camera to help identify UTIs in just minutes and delivers antibiotics to the patient. Women with suspected UTIs have access to clinical-grade care and get relief on the same day at home.

The laboratory test kits segment is projected to hold a large market share in the coming years, due to an increase in the number of visiting patients in hospitals. A laboratory test kit delivers meticulous test results on a mobile device within a minute. Laboratory test kits are more accurate as compared to home test kits.

End-user Type Segment Analysis

Based on end-user type the urinary tract infection testing market is divided into hospitals, diagnostic laboratories, research institutes, and others.

The diagnostic laboratories are expected to expand at the significant growth rate during the projection period, due to a rise in the number of UTI tests performed. These laboratories are equipped with costly instruments and need highly qualified staff and skilled people to conduct the UTI tests. Clinical laboratory tests provide accurate information which helps find problems that treat UTIs.

• In October 2023, Pathnostics received approval from the New York State Department of Health (NYSDOH) for its Guidance urinary tract infection (UTI) test. It enables fast diagnosis and accurate treatment of complicated, recurrent, and determined UTIs.

Get Free Sample Report

Regional Analysis

In terms of region, the global urinary tract infection testing market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa.

North America is expected to dominate the market during the projection period, due to the affordability of urinary tract infection testing among the target population. The regional market growth is further attributed to technological development for early detection of infections. UTIs are a major cause of doctor visits by adults, which is expected to increase the demand for urinary tract infection testing.

The market in Europe is anticipated to expand at a rapid pace in the coming years, due toa well-developed healthcare system. The regional market growth is further attributed to the availability of improved healthcare infrastructure such as diagnostic laboratories & clinics and preventive treatment. Increasing incidents of diabetes and kidney disease as well as the introduction of highly automated instruments are driving the market in the region.

• In July 2023, 2San partnered with Pharmacy2U, which is a large online pharmacy in the UK, to launch its self-diagnostic tests. It provides a fast diagnosis process, which helps patients decide the next appropriate step to take for their health.

  Get Free Sample Report